const e=()=>[{title:"ğŸ“– Management Summary",points:["**TAB_START:Summary**","## <u>**Meningitis in Pregnancy - Management Protocol**</u>","","### <u>**1. Emergency Assessment**</u>","â€¢ **Clinical Triad**: Fever, neck stiffness, altered mental status","â€¢ **Rapid Triage**: Immediate IV access, blood cultures, empirical antibiotics","â€¢ **Lumbar Puncture**: Urgent CSF analysis unless contraindicated","â€¢ **Imaging**: CT brain if focal signs, papilledema, or altered consciousness","","### <u>**2. Emergency Treatment**</u>","â€¢ **Empirical Antibiotics**: Ceftriaxone 2g IV q12h + Ampicillin 2g IV q4h","â€¢ **Steroids**: Dexamethasone 10mg IV q6h (if bacterial suspected)","â€¢ **Supportive**: IV fluids, oxygen, seizure control","â€¢ **Avoid Delays**: Don't wait for LP results to start treatment","","### <u>**3. Maternal-Fetal Monitoring**</u>","â€¢ **ICU Care**: Continuous neurological monitoring, ICP management","â€¢ **Fetal Assessment**: CTG monitoring if viable, delivery considerations","â€¢ **Complications**: Seizures, cerebral edema, septic shock","â€¢ **Family**: Contact tracing, chemoprophylaxis if indicated","","---","","**âš ï¸ Key Management Points:**","â€¢ Time-critical emergency - immediate antibiotics save lives","â€¢ Pregnancy increases risk of Listeria monocytogenes meningitis","â€¢ Early recognition and treatment prevent neurological sequelae","**TAB_END**"]},{title:"ğŸ§  Meningitis in Pregnancy - Comprehensive Clinical Overview",points:["ğŸ§  **Definition**: Meningitis in pregnancy is acute inflammation of meninges (pia, arachnoid, dura) caused by bacterial, viral, or other pathogens. Pregnancy-associated immunosuppression increases susceptibility, particularly to Listeria monocytogenes, with high maternal mortality (15-25%) and adverse fetal outcomes including death, prematurity, and neurological damage","ğŸ’€ **Maternal Mortality**: 15-25% in bacterial meningitis, higher than non-pregnant","ğŸ¤° **Pregnancy Risk**: 2-3 fold increased susceptibility to certain pathogens","ğŸ¦  **Unique Pathogen**: Listeria monocytogenes - 20x higher risk in pregnancy","ğŸ§  **Neurological Sequelae**: 30-50% survivors have permanent disabilities","âš¡ **Time-Critical**: Hours matter - delayed treatment increases mortality","ğŸ‘¶ **Fetal Effects**: 50-90% fetal mortality in untreated cases","ğŸ“ˆ **Increasing Incidence**: Rising with HIV, immunosuppression, travel"]},{title:"ğŸ“Š Meningitis Epidemiology - Global & Kenya Context",subsections:[{title:"ğŸŒ Global Meningitis in Pregnancy",points:["ğŸ“ˆ **Incidence**: 1-5 per 100,000 pregnancies globally","ğŸ’€ **Mortality**: 15-25% maternal, 50-90% fetal if untreated","ğŸ¦  **Pathogen Distribution**: Group B Strep (40%), Pneumococcus (25%), Listeria (20%)","ğŸŒ¡ï¸ **Seasonal**: Viral peaks winter, bacterial year-round","ğŸ“Š **Age Distribution**: Higher risk in teenage pregnancies","ğŸŒ **Geographic**: Meningitis belt Africa, pneumococcal worldwide","ğŸ’‰ **Vaccination Impact**: 80% reduction with Hib, pneumococcal vaccines","ğŸ“ˆ **Emerging**: Cryptococcal in HIV-endemic areas"]},{title:"ğŸ‡°ğŸ‡ª Kenya Meningitis Profile",points:["ğŸ“Š **National Incidence**: 15-25 per 100,000 pregnancies","ğŸ’€ **Case Fatality**: 20-35% in bacterial meningitis","ğŸ¦  **Common Pathogens**: Pneumococcus, Group B Strep, Cryptococcus, TB","ğŸŒ§ï¸ **Seasonal**: Meningococcal during dry season, viral during rains","ğŸ¦  **HIV Impact**: 15-30% cryptococcal meningitis in HIV patients","ğŸ’‰ **Vaccination**: Limited Hib, pneumococcal coverage","ğŸ¥ **Healthcare**: Delayed diagnosis, limited ICU facilities","ğŸ“ˆ **TB Meningitis**: 5-10% of CNS infections"]},{title:"ğŸ”ï¸ Nakuru County Specific Profile",points:["ğŸ“ **Geographic**: Highland region, cooler climate affects pathogens","ğŸ¦  **Pathogen Pattern**: More pneumococcal, less meningococcal","ğŸ¥ **Healthcare Access**: Referral hospital with CT, limited ICU","ğŸ‘¥ **Population**: Mixed urban-rural, migrant populations","ğŸ“Š **Burden**: 15-20 cases annually in pregnant women","ğŸŒ¡ï¸ **Seasonal**: Bacterial peaks during cold months","ğŸ’‰ **Prevention**: Improving vaccination coverage","ğŸ“ˆ **Trend**: Stable incidence, improving outcomes"]}]},{title:"ğŸ”¬ Pathogenesis of Meningitis in Pregnancy",subsections:[{title:"ğŸ¦  Routes of CNS Invasion",points:["ğŸ©¸ **Hematogenous Spread**: Most common route, bacteremia â†’ BBB crossing","ğŸ« **Respiratory Tract**: Pneumococcus, Haemophilus, viral pathogens","ğŸ½ï¸ **Gastrointestinal**: Listeria via contaminated food (pregnancy risk)","ğŸ¦· **Direct Extension**: Sinusitis, otitis media, dental infections","ğŸ§  **Traumatic**: Head trauma, neurosurgical procedures","ğŸŒŠ **Transplacental**: Some viral pathogens cross placenta","ğŸ’‰ **Iatrogenic**: Lumbar puncture, epidural procedures","ğŸ”„ **Reactivation**: Latent infections (HSV, VZV) in immunocompromised"]},{title:"ğŸ§  Blood-Brain Barrier Disruption",points:["ğŸ¦  **Bacterial Adherence**: Pili, adhesins bind to choroid plexus","ğŸ’¥ **Inflammatory Cascade**: TNF-Î±, IL-1Î², IL-6 increase permeability","ğŸŒŠ **Endothelial Damage**: Direct bacterial toxins, complement activation","ğŸ”¥ **Neutrophil Recruitment**: PMN infiltration, tissue damage","ğŸ’§ **Cerebral Edema**: Vasogenic and cytotoxic components","ğŸ©¸ **Hemorrhage**: Vessel necrosis, coagulopathy","âš¡ **Increased ICP**: Mass effect, CSF flow obstruction","ğŸ§¬ **Cellular Death**: Apoptosis, necrosis of neurons, glia"]},{title:"ğŸ¤° Pregnancy-Specific Factors",points:["ğŸ›¡ï¸ **Immune Suppression**: T-cell dysfunction, reduced complement","ğŸ¦  **Listeria Susceptibility**: Impaired cell-mediated immunity","ğŸ©¸ **Bacteremia Risk**: Increased invasive disease progression","ğŸ”„ **Hormonal Effects**: Estrogen, progesterone alter immune function","ğŸŒŠ **Physiological**: Increased blood volume, cardiac output","ğŸ§¬ **Placental Barrier**: Some pathogens cross, affect fetus","ğŸ’“ **Hemodynamic**: Hypotension poorly tolerated","âš¡ **Rapid Progression**: Faster deterioration than non-pregnant"]}]},{title:"âš”ï¸ Effects of Pregnancy on Meningitis Risk",subsections:[{title:"ğŸ›¡ï¸ Immunological Vulnerability",points:["ğŸ“‰ **Cell-Mediated Immunity**: Th1 suppression, impaired bacterial clearance","ğŸ”„ **Cytokine Shift**: Th2 dominance, reduced inflammatory response","ğŸ½ï¸ **Macrophage Function**: Reduced phagocytosis, bacterial killing","âš¡ **Complement**: Decreased complement activity, poor opsonization","ğŸ’€ **NK Cells**: Reduced natural killer cell activity","ğŸ¯ **Antibody**: Altered humoral immunity, reduced vaccine response","ğŸ§¬ **Memory**: Impaired immunological memory activation","ğŸ”¥ **Inflammation**: Blunted inflammatory response to pathogens"]},{title:"ğŸ¦  Pathogen-Specific Susceptibility",points:["ğŸ¥› **Listeria monocytogenes**: 20x increased risk, cell-mediated immunity dependent","ğŸŸ£ **Group B Streptococcus**: Increased invasive disease, bacteremia","ğŸ”µ **Streptococcus pneumoniae**: Higher risk of severe disease","ğŸ¦  **Cryptococcus**: Especially in HIV co-infection","ğŸ§¬ **Viral**: HSV, CMV reactivation, primary infections","ğŸ”´ **Tuberculosis**: Increased risk of CNS involvement","ğŸŸ¢ **Haemophilus**: Rare but severe when occurs","âš« **Toxoplasma**: Reactivation in HIV patients"]}]},{title:"ğŸ¤° Effects of Meningitis on Pregnancy",subsections:[{title:"ğŸ©¸ Maternal Complications",points:["ğŸ’€ **Mortality**: 15-25% in bacterial meningitis","ğŸ§  **Neurological**: Seizures (30%), focal deficits (25%), coma","ğŸ’§ **Cerebral Edema**: Increased ICP, herniation risk","âš¡ **Septic Shock**: Hypotension, organ dysfunction","ğŸ”¥ **SIRS**: Systemic inflammatory response syndrome","ğŸ§  **Hydrocephalus**: CSF flow obstruction","ğŸ©¸ **DIC**: Disseminated intravascular coagulation","ğŸ’“ **Cardiac**: Arrhythmias, myocarditis, failure"]},{title:"ğŸ‘¶ Fetal Complications",points:["ğŸ’€ **Fetal Death**: 50-90% if untreated, 10-30% if treated","â° **Preterm Birth**: 40-60% deliver prematurely","ğŸ¦  **Vertical Transmission**: Listeria, GBS, some viral","ğŸ§  **Neurological**: Brain damage, developmental delays","ğŸ“ **Growth Restriction**: Chronic inflammation, hypoxia","ğŸ¤° **Spontaneous Abortion**: First trimester infections","ğŸ©¸ **Hemorrhage**: Placental abruption, DIC","âš–ï¸ **Low Birth Weight**: Inflammatory effects, prematurity"]},{title:"ğŸ¤± Neonatal Effects",points:["ğŸ¦  **Neonatal Sepsis**: Early-onset, late-onset patterns","ğŸ§  **Meningitis**: Direct transmission, maternal pathogens","ğŸ« **Respiratory**: Distress syndrome, pneumonia","ğŸ’“ **Cardiovascular**: Shock, persistent pulmonary hypertension","ğŸ§¬ **Long-term**: Cerebral palsy, hearing loss, cognitive delays","ğŸ‘ï¸ **Sensory**: Vision, hearing impairment","ğŸ“ˆ **Development**: Delayed milestones, learning disabilities","ğŸ’€ **Mortality**: 15-30% neonatal death rate"]}]},{title:"ğŸ©º Clinical Presentation - Recognition & Assessment",subsections:[{title:"ğŸ§  Classic Meningitis Triad",points:["ğŸ”¥ **Fever**: >38Â°C in 95% cases, may be absent in elderly/immunocompromised","ğŸ¤• **Headache**: Severe, diffuse, worst headache of life","ğŸ¦´ **Neck Stiffness**: Nuchal rigidity, resistance to passive flexion","ğŸ§  **Altered Mental Status**: Confusion, lethargy, stupor, coma","âš¡ **Complete Triad**: Present in only 50% of cases","ğŸš¨ **Red Flags**: Rapid onset, photophobia, vomiting","ğŸ’« **Consciousness**: GCS <14 concerning, <8 critical","ğŸ¯ **Sensitivity**: High clinical suspicion needed"]},{title:"ğŸ” Physical Examination Signs",points:["ğŸ¦´ **Kernig's Sign**: Resistance to knee extension with hip flexed","ğŸ”„ **Brudzinski's Sign**: Neck flexion causes hip/knee flexion","ğŸ‘ï¸ **Papilledema**: Raised intracranial pressure (late sign)","ğŸ§  **Focal Deficits**: Cranial nerve palsies, hemiparesis","ğŸŸ£ **Rash**: Petechial, purpuric (meningococcal)","âš¡ **Seizures**: Generalized, focal, status epilepticus","ğŸ’« **Altered Consciousness**: Disorientation, delirium","ğŸŒ¡ï¸ **Vital Signs**: Fever, tachycardia, hypotension"]},{title:"ğŸ¤° Pregnancy-Specific Presentations",points:["ğŸ˜· **Flu-like Illness**: Myalgia, fatigue (especially viral)","ğŸ¤¢ **Gastrointestinal**: Nausea, vomiting, diarrhea (Listeria)","ğŸ« **Respiratory**: Cough, pharyngitis preceding CNS signs","ğŸ”¥ **Fever Pattern**: May be lower grade in pregnancy","âš¡ **Rapid Progression**: Faster deterioration than expected","ğŸ¤° **Obstetric**: Uterine contractions, cervical changes","ğŸ˜´ **Fatigue**: More severe than normal pregnancy tiredness","ğŸ§  **Confusion**: May be attributed to pregnancy brain fog"]},{title:"âš ï¸ Warning Signs & Severity Indicators",points:["ğŸ§  **Decreased GCS**: <13 indicates severe disease","âš¡ **Seizures**: Generalized or focal, status epilepticus","ğŸ’“ **Hemodynamic Instability**: Hypotension, tachycardia","ğŸ« **Respiratory**: Irregular breathing, apnea","ğŸ‘ï¸ **Pupillary**: Unequal, unreactive pupils","ğŸ”„ **Posturing**: Decerebrate, decorticate posturing","ğŸ’€ **Coma**: Unresponsive to stimuli","ğŸ¤° **Fetal Distress**: Bradycardia, absent movements"]}]},{title:"ğŸ” Examination Findings",subsections:[{title:"ğŸ§  Neurological Assessment",points:["ğŸ’« **Mental Status**: Alert to comatose, GCS scoring","ğŸ‘ï¸ **Cranial Nerves**: III, VI, VII, VIII palsies common","ğŸ’ª **Motor**: Weakness, paralysis, abnormal movements","ğŸ”„ **Reflexes**: Hyperreflexia, pathological reflexes","ğŸ‘‚ **Sensory**: Reduced sensation, pain responses","ğŸš¶ **Coordination**: Ataxia, dysmetria if conscious","ğŸ—£ï¸ **Speech**: Dysarthria, aphasia, dysphonia","âš–ï¸ **Balance**: Vertigo, nystagmus, falls"]},{title:"ğŸŒ¡ï¸ General Physical Findings",points:["ğŸŒ¡ï¸ **Temperature**: Fever, hypothermia in shock","ğŸ’“ **Cardiovascular**: Tachycardia, hypotension, murmurs","ğŸ« **Respiratory**: Tachypnea, irregular patterns","ğŸŸ£ **Skin**: Rash (meningococcal), pallor, cyanosis","ğŸ‘ï¸ **Eyes**: Photophobia, papilledema, hemorrhages","ğŸ‘‚ **ENT**: Otitis, sinusitis, pharyngitis","ğŸ¦´ **Musculoskeletal**: Rigidity, arthritis","ğŸ¥ **Abdomen**: Distension, organomegaly"]},{title:"ğŸ¤° Obstetric Assessment",points:["ğŸ“ **Fundal Height**: Appropriate for dates","ğŸ‘‚ **Fetal Heart**: Continuous monitoring if viable","ğŸ”„ **Uterine Activity**: Contractions, irritability","ğŸŒŠ **Amniotic Fluid**: Volume assessment","ğŸ©¸ **Vaginal**: Bleeding, discharge, membrane status","ğŸ“Š **Biophysical Profile**: Fetal well-being assessment","âš–ï¸ **Estimated Weight**: Growth parameters","ğŸ’“ **Maternal Vitals**: Impact on uteroplacental flow"]}]},{title:"ğŸ”¬ Comprehensive Diagnostic Workup",subsections:[{title:"ğŸ§  Lumbar Puncture & CSF Analysis",points:["âš¡ **Urgent LP**: Don't delay if no contraindications","ğŸš« **Contraindications**: Raised ICP signs, coagulopathy, skin infection","ğŸ–¼ï¸ **Pre-LP Imaging**: CT if focal signs, GCS <12, papilledema","ğŸ”¬ **CSF Studies**: Cell count, protein, glucose, Gram stain, culture","ğŸ§¬ **Molecular**: PCR for bacteria, viruses, TB","ğŸ’§ **Opening Pressure**: >300mmHâ‚‚O suggests raised ICP","ğŸ¯ **Antigen Tests**: Pneumococcal, GBS, cryptococcal","ğŸ“Š **CSF Patterns**: Bacterial vs viral vs TB differentiation"]},{title:"ğŸ©¸ Laboratory Investigations",points:["ğŸ“Š **Complete Blood Count**: Leukocytosis, neutrophilia, bands","ğŸ”¥ **Inflammatory Markers**: CRP, ESR, procalcitonin elevation","ğŸ§ª **Blood Chemistry**: Glucose, electrolytes, liver/renal function","ğŸ©¸ **Blood Cultures**: Before antibiotics, 2 sets different sites","ğŸ’‰ **Coagulation**: PT/PTT, platelets, fibrinogen","ğŸ§¬ **Molecular**: Blood PCR for pathogens","ğŸ’§ **Lactate**: Elevated in bacterial infections","ğŸ¯ **Specific Tests**: Cryptococcal antigen, TB interferon-Î³"]},{title:"ğŸ–¼ï¸ Imaging Studies",points:["ğŸ§  **CT Brain**: Rule out mass effect, hemorrhage, hydrocephalus","ğŸ§² **MRI Brain**: Superior for early changes, complications","ğŸ“¸ **Chest X-ray**: Primary source identification","ğŸ¦´ **CT Sinuses**: If sinusitis suspected","ğŸ‘¶ **Obstetric US**: Fetal well-being, placental assessment","ğŸ’“ **Echocardiogram**: If endocarditis suspected","ğŸ« **CT Chest**: If pulmonary source suspected","ğŸ“± **Point-of-Care**: Bedside ultrasound for complications"]},{title:"ğŸ”¬ Specialized Diagnostics",points:["ğŸ§¬ **Multiplex PCR**: Rapid pathogen identification","ğŸ¦  **Antigen Testing**: Rapid diagnosis (pneumococcal, GBS)","ğŸ”¬ **Microscopy**: Acid-fast stain for TB, India ink for crypto","ğŸ“Š **Biomarkers**: Procalcitonin, lactate dehydrogenase","ğŸ§ª **Serological**: Viral titers, syphilis screening","âš¡ **Rapid Tests**: Point-of-care pathogen detection","ğŸ¯ **Susceptibility**: Antibiotic sensitivity testing","ğŸ“ˆ **Monitoring**: Serial CSF analysis if indicated"]}]},{title:"ğŸ’Š Emergency Treatment Protocols",subsections:[{title:"âš¡ Immediate Management (First Hour)",points:["ğŸš¨ **ABC Assessment**: Airway, breathing, circulation","ğŸ’‰ **IV Access**: Large bore, blood cultures, empirical antibiotics","ğŸ§  **Neurological**: GCS, pupil response, focal signs","ğŸ”¥ **Empirical Antibiotics**: Don't wait for LP results","ğŸ’Š **Steroids**: Dexamethasone if bacterial suspected","ğŸŒ¡ï¸ **Supportive**: Antipyretics, seizure control","ğŸ“Š **Monitoring**: Continuous vitals, neurological checks","ğŸ¤° **Obstetric**: Fetal monitoring if viable gestation"]},{title:"ğŸ’‰ Empirical Antibiotic Therapy",points:["ğŸ”µ **Standard Regimen**: Ceftriaxone 2g IV q12h","ğŸ¥› **Add Ampicillin**: 2g IV q4h (Listeria coverage in pregnancy)","ğŸŸ¢ **Alternative**: Cefotaxime 2g IV q6h if ceftriaxone unavailable","âš ï¸ **Penicillin Allergy**: Vancomycin + meropenem","ğŸ’Š **Dexamethasone**: 10mg IV q6h Ã— 4 days (bacterial)","ğŸ§  **Duration**: Continue until pathogen identified","ğŸ“Š **Monitoring**: Clinical response, repeat LP if indicated","ğŸ¯ **Adjustment**: Based on culture and sensitivity"]},{title:"ğŸ¦  Pathogen-Specific Treatment",points:["ğŸ”µ **Pneumococcal**: Ceftriaxone 2g q12h or penicillin if sensitive","ğŸ¥› **Listeria**: Ampicillin 2g q4h + gentamicin","ğŸŸ£ **Group B Strep**: Penicillin G 4 million units q4h","ğŸŸ¢ **Haemophilus**: Ceftriaxone 2g q12h","ğŸ”´ **Meningococcal**: Penicillin G or ceftriaxone","ğŸ–¤ **Cryptococcal**: Amphotericin B + flucytosine","ğŸ§¬ **Viral**: Acyclovir if HSV/VZV suspected","ğŸ”´ **TB Meningitis**: Anti-TB therapy + steroids"]}]},{title:"ğŸ¥ Intensive Care Management",subsections:[{title:"ğŸ§  Neurological Monitoring",points:["ğŸ’« **Consciousness**: Hourly GCS assessment","ğŸ‘ï¸ **Pupils**: Size, reactivity, asymmetry","ğŸ§  **ICP Monitoring**: If available, target <20mmHg","âš¡ **Seizures**: EEG monitoring, antiepileptic drugs","ğŸ’§ **Cerebral Edema**: Mannitol, hypertonic saline","ğŸ”„ **Positioning**: Head elevation 30-45 degrees","ğŸŒ¡ï¸ **Temperature**: Target normothermia","ğŸ“Š **Neuro Checks**: Q1-2 hours initially"]},{title:"ğŸ’“ Hemodynamic Support",points:["ğŸ©¸ **Blood Pressure**: Target MAP >65mmHg","ğŸ’‰ **Vasopressors**: Norepinephrine first-line","ğŸ’§ **Fluid Management**: Avoid overload, euvolemia","ğŸ’“ **Cardiac**: Monitor for myocarditis, arrhythmias","ğŸ«˜ **Renal**: Urine output >0.5ml/kg/hr","âš¡ **Electrolytes**: Monitor sodium, glucose closely","ğŸ“Š **Central Access**: CVP monitoring if shocked","ğŸ¯ **Targets**: Individualized based on pregnancy"]},{title:"ğŸ¤° Obstetric Considerations",points:["ğŸ‘‚ **Continuous CTG**: If viable gestation (>24 weeks)","ğŸ¤° **Delivery Timing**: Balance maternal vs fetal risks","ğŸ’Š **Corticosteroids**: Lung maturity if preterm delivery likely","ğŸ”„ **Position**: Left lateral to optimize placental flow","ğŸ“Š **Monitoring**: Uterine activity, cervical changes","ğŸ©¸ **Bleeding**: Monitor for abruption, DIC","âš¡ **Emergency**: Perimortem cesarean if cardiac arrest","ğŸ‘¶ **Neonatal**: Pediatric team involvement"]}]},{title:"âš ï¸ Complications & Long-term Effects",subsections:[{title:"ğŸ’€ Acute Complications",points:["ğŸ§  **Cerebral Edema**: Mass effect, herniation syndromes","ğŸ’§ **Hydrocephalus**: CSF flow obstruction, shunt requirement","âš¡ **Seizures**: Status epilepticus, refractory epilepsy","ğŸ©¸ **Stroke**: Arterial/venous thrombosis, hemorrhage","ğŸ’“ **Septic Shock**: Multi-organ dysfunction","ğŸ« **ARDS**: Respiratory failure, mechanical ventilation","ğŸ§¬ **DIC**: Bleeding, thrombosis complications","ğŸ«˜ **Renal Failure**: Acute tubular necrosis"]},{title:"ğŸ“ˆ Long-term Neurological Sequelae",points:["ğŸ‘‚ **Hearing Loss**: 10-30% survivors, cochlear damage","ğŸ§  **Cognitive Impairment**: Memory, executive function deficits","âš¡ **Epilepsy**: 5-15% develop chronic seizures","ğŸ’ª **Motor Deficits**: Hemiparesis, quadriparesis, ataxia","ğŸ—£ï¸ **Speech**: Dysarthria, aphasia, language delays","ğŸ‘ï¸ **Visual**: Field defects, cortical blindness","ğŸ§  **Behavioral**: Personality changes, depression, anxiety","ğŸ“š **Learning**: Difficulties, need special education"]},{title:"ğŸ‘¶ Fetal & Neonatal Outcomes",points:["ğŸ’€ **Mortality**: 10-30% fetal/neonatal death","â° **Prematurity**: 40-60% preterm delivery","ğŸ§  **Neurological**: Cerebral palsy, developmental delays","ğŸ‘‚ **Sensory**: Hearing, vision impairment","ğŸ“ **Growth**: IUGR, low birth weight","ğŸ¦  **Infection**: Vertical transmission risk","ğŸ« **Respiratory**: Distress syndrome complications","ğŸ“ˆ **Development**: Long-term neurodevelopmental issues"]}]},{title:"ğŸ›¡ï¸ Prevention & Prophylaxis",subsections:[{title:"ğŸ’‰ Vaccination Strategies",points:["ğŸ”µ **Pneumococcal**: PCV13/PPSV23 before pregnancy","ğŸŸ¢ **Haemophilus**: Hib vaccine childhood series","ğŸ”´ **Meningococcal**: MenACWY, MenB if high risk","ğŸŒ¡ï¸ **Influenza**: Annual vaccination during pregnancy","ğŸ¤± **Tdap**: Whooping cough, third trimester","ğŸ“… **Timing**: Most vaccines before pregnancy","ğŸ¯ **High-Risk**: Immunocompromised, travel","ğŸ‘¶ **Infant**: On-time childhood immunizations"]},{title:"ğŸ  Environmental & Lifestyle",points:["ğŸ½ï¸ **Food Safety**: Avoid unpasteurized products (Listeria)","ğŸ¤ **Hand Hygiene**: Frequent handwashing","ğŸ˜· **Mask Wearing**: During outbreaks","ğŸ‘¥ **Avoid Crowds**: High-risk periods","ğŸ  **Ventilation**: Good air circulation","ğŸš¬ **No Smoking**: Increases susceptibility","ğŸ½ï¸ **Nutrition**: Adequate protein, vitamins","ğŸ’ª **Exercise**: Moderate, immune function"]},{title:"ğŸ‘¥ Contact Management",points:["ğŸ’Š **Chemoprophylaxis**: Close contacts of meningococcal","ğŸ” **Contact Tracing**: Identify exposed individuals","ğŸ“Š **Surveillance**: Monitor for secondary cases","ğŸ’‰ **Vaccination**: Post-exposure if indicated","ğŸ¥ **Healthcare Workers**: Standard precautions","ğŸ‘¥ **Household**: Antibiotic prophylaxis protocols","ğŸ¯ **High-Risk**: Pregnant contacts priority","ğŸ“± **Reporting**: Public health notification"]}]},{title:"ğŸ‡°ğŸ‡ª Kenya-Specific Considerations",points:["ğŸ¥ **Healthcare Access**: Limited ICU facilities, delayed diagnosis","ğŸ¦  **HIV Co-infection**: Cryptococcal meningitis common","ğŸ’‰ **Vaccination**: Limited Hib, pneumococcal coverage","ğŸ”´ **TB Meningitis**: 5-10% of CNS infections","ğŸŒ§ï¸ **Seasonal**: Viral during rainy season","ğŸ’° **Socioeconomic**: Poverty affects healthcare access","ğŸ˜ï¸ **Overcrowding**: Increased transmission risk","ğŸ“± **mHealth**: Mobile platforms for awareness","ğŸ¤ **Traditional**: Herbalist consultations delay care","ğŸ“Š **Surveillance**: Improved reporting systems needed"]}];export{e as getMeningitisPregnancyContent};
